34 results
424B3
HOTH
Hoth Therapeutics Inc
22 Apr 24
Prospectus supplement
4:15pm
the application has been accepted for filing by the FDA. The NDA holder or patent owner may then initiate a patent infringement lawsuit in response to notice … of the Paragraph IV Certification. The filing of a patent infringement lawsuit within 45 days of the receipt of a Paragraph IV Certification prevents
8-K
EX-10.1
HOTH
Hoth Therapeutics Inc
15 Sep 23
Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:15pm
lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its
8-K
EX-10.1
yacub 4ztt15
30 Dec 22
Hoth Therapeutics Announces $10 Million Private Placement
4:15pm
8-K
EX-1.1
xic4r
13 Apr 22
Hoth Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
5:11pm
8-K
EX-10.1
ohrvkrhhug3vozy1vp
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
EX-10.1
0bholwa3ev45gy3
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
424B3
56ony6
7 May 20
Prospectus supplement
6:02am
424B3
lj48ythjbeo1q
25 Oct 19
Prospectus supplement
5:12pm
424B3
0onr28al7c er8ct0kp1
16 Sep 19
Prospectus supplement
5:06pm